< ![CDATA[

Economic Effect of Following HbA1c Testing Practice Guidelines in the Elderly Medicare Population: An Instrumental Variable Analysis.

Am J Med Qual. 2010 Jan 28;

Authors: Li S, Liu J, Gilbertson DT, Collins AJ

This retrospective follow-up study aimed to evaluate the effect of following glycated hemoglobin (HbA1c) testing practice guidelines on Medicare expenditures. The authors identified 12 635 incident diabetes patients from 1998 and 1999 Medicare 5% claims data and calculated Medicare payments from 2000 to 2003. They applied a 2-stage least-squares model with instrumental variable (IV) methodology to estimate the effect of receiving >/=2 HbA1c tests annually on Medicare expenditures. Only 27.7% (3503/12 635) of the sample received >/=2 HbA1c tests annually. IV estimation results showed that receiving the tests was associated with a $953 decrease in Medicare payments per patient-year. Improved HbA1c test rates could save Medicare costs. For each year, 2000 to 2003, the authors estimate that approximately $174 million in Medicare expenditures could have been saved through Medicare patients aged >/=67 years who developed diabetes in 1998 and 1999, had no diabetes complications at baseline, and subsequently did not receive >/=2 HbA1c tests annually.

PMID: 20110455 [PubMed - as supplied by publisher]

]]>

Der Beitrag wurde am Donnerstag, den 28. Januar 2010 um 07:55 Uhr veröffentlicht und wurde unter Am J Med Qual abgelegt. du kannst die Kommentare zu diesen Eintrag durch den RSS 2.0 Feed verfolgen. du kannst einen Kommentar schreiben, oder einen Trackback auf deiner Seite einrichten.